Neil Kumar

Insider Reports History

Entity
Individual
Location
C/O Bridgebio Pharma, Inc., 3160 Porter Dr, Ste 250, Palo Alto, CA
Signature
/s/ Brian C. Stephenson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Neil Kumar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. Chief Executive Officer, Director Common Stock 4.9M $111M $22.76 Nov 19, 2024 Direct
BridgeBio Pharma, Inc. Chief Executive Officer, Director Common Stock 1.01M $23.1M $22.76 Nov 19, 2024 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
BridgeBio Pharma, Inc. Chief Executive Officer, Director Common Stock 996K $22.7M $22.76 Nov 19, 2024 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
LianBio Director Ordinary Shares 5M $8.27M $1.65 Oct 29, 2021 By BridgeBio Pharma LLC
BridgeBio Pharma, Inc. Chief Executive Officer, Director Restricted Stock Units 122K $2.78M $22.76 Dec 10, 2024 Direct
BridgeBio Pharma, Inc. Chief Executive Officer, Director Stock Option (right to buy) 45.1K Mar 12, 2024 Direct

Insider Reports Filed by Neil Kumar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBIO BridgeBio Pharma, Inc. Dec 10, 2024 1 $0 4 Dec 12, 2024 Chief Executive Officer, Director
BBIO BridgeBio Pharma, Inc. Nov 19, 2024 2 -$614K 4 Nov 20, 2024 Chief Executive Officer, Director
BBIO BridgeBio Pharma, Inc. Nov 16, 2024 5 -$668K 4 Nov 19, 2024 Chief Executive Officer, Director
BBIO BridgeBio Pharma, Inc. Aug 16, 2024 7 -$1.36M 4 Aug 20, 2024 Chief Executive Officer, Director
BBIO BridgeBio Pharma, Inc. May 16, 2024 6 -$954K 4 May 17, 2024 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Mar 12, 2024 2 $0 4 Mar 14, 2024 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Feb 16, 2024 6 -$1.78M 4 Feb 21, 2024 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Nov 16, 2023 8 -$2.96M 4 Nov 20, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Aug 16, 2023 7 -$2.98M 4 Aug 18, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. May 16, 2023 7 -$1.44M 4 May 18, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. May 3, 2023 1 -$1.7M 4 May 5, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Apr 5, 2023 1 -$1.86M 4 Apr 7, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Mar 3, 2023 1 -$1.32M 4 Mar 3, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Feb 16, 2023 6 -$871K 4 Feb 21, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Feb 3, 2023 1 -$1.32M 4 Feb 6, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Jan 5, 2023 1 -$921K 4 Jan 6, 2023 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Dec 21, 2022 1 $0 4 Dec 21, 2022 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Nov 16, 2022 6 -$654K 4 Nov 18, 2022 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Aug 16, 2022 5 -$307K 4 Aug 18, 2022 CEO and President, Director
BBIO BridgeBio Pharma, Inc. May 16, 2022 5 -$160K 4 May 18, 2022 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Mar 16, 2022 1 $0 4 Mar 18, 2022 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Feb 16, 2022 4 -$27.3K 4 Feb 18, 2022 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Dec 3, 2021 1 $0 4 Dec 7, 2021 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Nov 16, 2021 4 -$176K 4 Nov 18, 2021 CEO and President, Director
LIAN LianBio Oct 29, 2021 0 $0 3/A Nov 9, 2021 Director
BBIO BridgeBio Pharma, Inc. Aug 16, 2021 4 -$185K 4 Aug 18, 2021 CEO and President, Director
BBIO BridgeBio Pharma, Inc. May 16, 2021 4 -$200K 4 May 18, 2021 CEO and President, Director
BBIO BridgeBio Pharma, Inc. Feb 10, 2021 2 $0 4 Feb 14, 2023 CEO and President, Director